A Review on Central Nervous System Effects of Gastrodin.
Liu Y, Gao J, Peng M, Meng H, Ma H, Cai P, Xu Y, Zhao Q, Si G. · 2018
Read A Review on Central Nervous System Effects of Gastrodin. by Liu Y, Gao J, Peng M, Meng H, Ma H, Cai P, Xu Y, Zhao Q, Si G. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5801292.txt.
Introduction
Liu and co-authors review gastrodin, the main active part of a Chinese herb. The herb, Tian ma, comes from the orchid Gastrodia elata. Healers used it for centuries for headache, dizziness, and seizures. Gastrodin was first isolated in 1978.
The review gathers lab studies on brain and nerve disorders. They cover epilepsy, Alzheimer's, and Parkinson's disease. They also cover stroke damage, mood disorders, and memory loss. Gastrodin seems to calm nerve signals and cut cell stress. The authors note that firm clinical trials are still lacking. Readers get a broad survey of promise and gaps.
Catalog record
| CREATOR | Liu Y, Gao J, Peng M, Meng H, Ma H, Cai P, Xu Y, Zhao Q, Si G. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 88 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
A Review on Central Nervous System Effects of Gastrodin By Yuan Liu, Jialiang Gao, Min Peng, Hongyan Meng, Hongbo Ma, Pingping Cai, Yuan Xu, Qiong Zhao, Guomin Si Published in: Frontiers in Pharmacology DOI: 10.3389/fphar.2018.00024 ABSTRACT Abstract Rhizoma Gastrodiae (also known as Tian ma), the dried rhizome of Gastrodia elata Blume, is a famous Chinese herb that has been traditionally used for the treatment of headache, dizziness, spasm, epilepsy, stoke, amnesia and other disorders for centuries. Gastrodin, a phenolic glycoside, is the main bioactive constituent of Rhizoma Gastrodiae. Since identified in 1978, gastrodin has been extensively investigated on its pharmacological properties. In this article, we reviewed the central nervous system (CNS) effects of gastrodin in preclinical models of CNS disorders including epilepsy, Alzheimer's disease, Parkinson's disease, affective disorders, cerebral ischemia/reperfusion, cognitive impairment as well as the underlying mechanisms involved and, where possible, clinical data that support the pharmacological activities. The sources and pharmacokinetics of gastrodin were also reviewed here. As a result, gastrodin possesses a broad range of beneficial effects on the above-mentioned CNS diseases, and the mechanisms of actions include modulating neurotransmitters, antioxidative, anti-inflammatory, suppressing microglial activation, regulating mitochondrial cascades, up-regulating neurotrophins, etc. However, more detailed clinical trials are still in need for positioning it in the treatment of neurological disorders. Keywords: Gastrodia, Gastrodia elata Blume, Chinese medicine, pharmacology, pharmacokinetics, central nervous system disorders INTRODUCTION A central nervous system (CNS) disorder refers to a disease that affects the structure or function of brain or spinal cord, thus causing neurological or psychiatric complications (Kundap et al., 2017). In recent decades, the number of people suffering from CNS disorders has grown dramatically due to the increase of life expectancy, placing a tremendous burden on families and social economies (Alavijeh et al., 2005). However, although much progress have been made in understanding the underlying mechanisms of these disorders, there are no effective therapy to prevent or stop the progression of these conditions (Upadhyay, 2014), and the existing drugs have only symptomatic effects as well as many adverse reactions, calling for a strong need for identifying novel therapeutic opportunities (Kazantsev and Outeiro, 2010). In this context, herbal plants and their bioactive compounds have drawn much attention in their potential as new treatment options for CNS disorders (World Health Organization, 1999). Actually, several compounds with strong actions derived from herbs, such as cannabidivarin, cannabidiol, and huperzine A, have recently been developed as drug candidates in western countries (Bialer et al., 2015). Gastrodia elata Blume (G. elata) is a notable herbal plant that has been traditionally used to treat various conditions including headache, dizziness, spasm, epilepsy, stoke, amnesia, and other disorders in oriental countries for centuries (Chinese Pharmacopoeia Commission, 2015). The main medicinal part is its rhizome, called Rhizoma Gastrodiae. Since 1950s, over 81 compounds have been isolated from G. elata including phenolics, polysaccharides, organic acids, sterols, etc. (Duan et al., 2013). Gastrodin (PubChem CID: 115027), a phenolic glycoside that chemically known as 4-hydroxybenzyl alcohol-4-O-β-D-glucopyranoside, is the second compound identified from the plant after vanilyalcohol, which was isolated in 1958 (Liu and Yang, 1958), and is considered to be the main bioactive constituent of Rhizoma Gastrodiae. Furthermore, the content of gastrodin is assayed as the most important phytochemical marker in the quality standardization of Rhizoma Gastrodiae (Tao et al., 2009). With a molecular formula of C13H18O7 and a molecular weight of 286 Da, gastrodin is easy to dissolve in methanol, ethanol and water, while it is difficult to dissolve in chloroform and ether. The chemical structural formula of gastrodin is shown as Figure 1 (Zhou et al., 1979). [Figure: The chemical structural formula of Gastrodin.] In 1978, two laboratories simultaneously reported the isolation of gastrodin along with other six compounds from the ethanolic extract of G. elata (Feng et al., 1979; Zhou et al., 1979). Since then, gastrodin have been extensively investigated on its biological actions. As a result, numerous pharmacological activities have been attributed to gastrodin, including sedative, hypnotic (Deng and Mo, 1979), anti-vertigo (Chen et al., 2004), analgesic (Zhang et al., 2006), anti-epileptic (Ojemann et al., 2006), antidepressant (Chen and Sheen, 2011), anxiolytic (Peng et al., 2013), memory-improving (Hsieh et al., 1997), anti-aging (Wang Z. J. et al., 2007), lowering blood pressure (Zhang Q. et al., 2008), preventing osteonecrosis (Zheng et al., 2014) effects, etc. Among its various pharmacological properties, its strong actions in CNS diseases appear to be particularly prominent. Considering its low toxicity and remarkable pharmacological performance, gastrodin might be a potential valuable therapeutic for the prevention and treatment of some CNS disorders (Zhan et al., 2016). However, up to now, although several reviews on G. elata have been conducted (Chen and Sheen, 2011; Jang et al., 2015; Matias et al., 2016; Zhan et al., 2016), in which gastrodin and its therapeutic effects were sporadically mentioned, the pharmacological properties of gastrodin has not been systematically reviewed. In this article, focusing on the neuropharmacological properties of gastrodin, the therapeutic effects of gastrodin in preclinical models of CNS disorders including epilepsy, Alzheimer's disease, Parkinson's disease, affective disorders, cerebral ischemia/reperfusion, and cognitive impairment were reviewed (Tables 1, 2) as well as the underlying mechanisms involved (Figure 2) and, where possible, clinical data that support therapeutic effects (Table 3). In addition, the sources, pharmacokinetics, and toxicity of gastrodin were also reviewed here. [Table: Effects of Gastrodin in in vivo models of epilepsy.] [Table: Effects of Gastrodin in in vivo and in vitro models of AD, PD, anxiety, depression, I/R, VD and cognitive impairment.] [Figure: Mechanisms of action of gastrodin in CNS disorders.] [Table: Clinical trials performed of gastrodin for CNS disorders.] G. ELATA, RHIZOMA GASTRODIAE, AND GASTRODIN G. elata (Orchidaceae) is a famous traditional Chinese herb that has been used for centuries. Rhizoma Gastrodiae, the dried rhizome of G. elata, is the main medicinal part of the plant. Gastrodin is the main bioactive component of Rhizoma Gastrodiae. Botanical aspects of G. elata G. elata, commonly known as Tianma, is a saprophytic perennial herb that belongs to the genus Gastrodia, family Orchidaceae. It is primarily found in eastern Asia, specifically in the mountainous areas of China, Korea, Japan, and India (Shuan and Chen, 1983; Jones, 1991). In China, it grows mainly in Sichuan, Guizhou, Yunnan, and other provinces (Chinese Academy of Sciences, 2004). In ancient times, it was also called Chijian, Guiduyou, Duyaozhi, or Mingtianma, which are out of use nowadays. It grows in wet place with a lot of humus, especially in humid mountainous areas at an altitude of 400–3,200 m above sea level and depends on the fungus Armillaria mellea for nutriments (Wang M.-W. et al., 2007). Great demand has led to overexploitation of the plant, and its wild species has been listed as an endangered species in China (Chen et al., 2011). For this reason, great efforts have been made toward its preservation and cultivation (Chen Y. Y. et al., 2014), and since it was successfully cultivated in the 1970s, home-grown species has gradually become the main source of the plant (Xu and Guo, 2000). G. elata lives underground during its life cycle except for florescence. The whole plant is free of chlorophyll, which is the unique botanical character of it. It grows to the height of 30–150 cm and the stems are